These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 7065738)
1. Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective. Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):1-60. PubMed ID: 7065738 [No Abstract] [Full Text] [Related]
3. New therapeutics in rheumatoid arthritis. Savage C; St Clair EW Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821 [TBL] [Abstract][Full Text] [Related]
5. "Disease-modifying" drugs in rheumatoid arthritis. Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082 [No Abstract] [Full Text] [Related]
6. Immunosuppressive therapy in rheumatoid arthritis. Rainer F Acta Med Austriaca; 1988; 15(5):137-40. PubMed ID: 3064524 [TBL] [Abstract][Full Text] [Related]
7. The choice of, and the decision to apply, disease modifying drugs. Barnes CG Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):1-2. PubMed ID: 7065737 [No Abstract] [Full Text] [Related]
8. Immunosuppression in the treatment of rheumatoid arthritis. Basic principles and available substances. Andreis M Adv Clin Pharmacol; 1974; 6():81-8. PubMed ID: 4468718 [No Abstract] [Full Text] [Related]
9. Investigational agents for rheumatoid arthritis. Merkel PA; Letourneau EN; Polisson RP Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099 [TBL] [Abstract][Full Text] [Related]
10. [Biological immunosuppression and rheumatoid inflammation]. Rodriguez de Llano J; Aguilera Franco M Rev Esp Reum Enferm Osteoartic; 1977; 20(1):47-64. PubMed ID: 300893 [No Abstract] [Full Text] [Related]
11. [Cyclosporin A in the treatment of refractory rheumatoid arthritis]. Trnavský K Cas Lek Cesk; 1995 Nov; 134(22):731-4. PubMed ID: 8599812 [TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis: diagnosis and management. Majithia V; Geraci SA Am J Med; 2007 Nov; 120(11):936-9. PubMed ID: 17976416 [TBL] [Abstract][Full Text] [Related]
13. Uncommon cutaneous lymphoproliferative disorders in two patients with rheumatoid arthritis. Carroll M; Biswas N; Wheller L; Shepherd V; Strutton GM Australas J Dermatol; 2017 Aug; 58(3):e101-e104. PubMed ID: 27029566 [TBL] [Abstract][Full Text] [Related]
14. [Experience with immunosuppressive therapy in rheumatoid arthritis?]. Mathies H Dtsch Med Wochenschr; 1968 Jan; 93(2):95. PubMed ID: 5634965 [No Abstract] [Full Text] [Related]
15. Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis. Arnold M; Schrieber L; Brooks P Drugs; 1988 Sep; 36(3):340-63. PubMed ID: 3056693 [TBL] [Abstract][Full Text] [Related]
17. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"]. Krüger K MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140 [No Abstract] [Full Text] [Related]
18. [Symposium II. Immunosuppressive therapy in rheumatoid arthritis. 3. Pathologic effects of immunosuppressive agents and their adverse anti-inflammatory effects]. Kyogoku M; Watanabe S; Sagino H; Obu R; Shimomura R Ryumachi; 1973 Jan; 13(1):38-47. PubMed ID: 4726791 [No Abstract] [Full Text] [Related]
19. [Immunosuppressive cytostatic preparations in the therapy of certain diseases]. Petrov NS; Dygin VP; Viazitskiĭ PO; Tokarev NF Voen Med Zh; 1975 Sep; (9):43-7. PubMed ID: 1181721 [No Abstract] [Full Text] [Related]
20. [Indications and limitations of immunosuppressive treatment in rheumatoid arthritis]. Chlud K Reumatizam; 1972; 19(1):1-8. PubMed ID: 5023361 [No Abstract] [Full Text] [Related] [Next] [New Search]